BERLIN, May 29, 2025 /PRNewswire/ — MAMMOTION, the pioneer in robotic lawn care, today announced its partnership with the BERLIN TENNIS OPEN. This collaboration units cutting-edge lawn technology with the precision of elite sports, redefining excellence both on and off the court.

As a prestigious pre-Wimbledon tournament, the BERLIN TENNIS OPEN captivates an audience of over 12 million European tennis enthusiasts, offering MAMMOTION a strategic platform to engage with high-end consumers. By leveraging the event’s visibility and prestige, MAMMOTION strengthens its position as a premier brand in advanced, intelligent lawn care solutions.

The tournament’s core values of precision, perseverance, and excellence closely mirror MAMMOTION’s commitment to redefining the future of lawn care through robotics and innovation. This synergy allows MAMMOTION to expand its influence, reinforce its leadership in the industry, and further establish itself as the go-to choice for smart, effortless outdoor maintenance.

Just as elite athletes demand precision and performance on the court, MAMMOTION’s robotic mowers bring effortless perfection to outdoor spaces. As the official premium partner of the Berlin Tennis Open, MAMMOTION will showcase its dedication to seamlessly integrating smart technology with effortless lawn care, helping homeowners achieve excellence in every aspect of life.

“Partnering with the BERLIN TENNIS OPEN is a natural fit,” said Jayden Wei, CEO of MAMMOTION. “Both champions—whether on the court or in the garden—strive for perfection. Our robots don’t just mow; they calculate every move like a grand slam strategy, delivering flawless results without the sweat.”

“We’re delighted to welcome MAMMOTION as our premium partner. This partnership celebrates how technology and sports can inspire each other—just as our players master their craft, MAMMOTION’s innovations are mastering the art of lawn care.”
— Markus Zoecke, Tournament Director BERLIN TENNIS OPEN.

During the tournament, MAMMOTION will offer live demonstrations, allowing visitors to experience firsthand how its state-of-the-art robotic technology is revolutionizing lawn care. Attendees will also have the opportunity to explore MAMMOTION’s commitment to innovation, sustainability, and intelligent design.

MAMMOTION and the BERLIN TENNIS OPEN share a vision: elevating daily life through innovation.

For more information about MAMMOTION and its products, please visit https://mammotion.com/.

About BERLIN TENNIS OPEN

The BERLIN TENNIS OPEN is a traditional WTA tennis tournament, which brings together the elite of women’s tennis every year on the picturesque lawns of the LTTC “Rot-Weiß”. The BERLIN TENNIS OPEN was first held as a clay court tournament in 1979. After an interruption, it was revived in 2021 as a first-class grass court tournament. Today, the WTA 500 category tournament takes place after the French Open and offers international tennis stars the opportunity to prepare in Berlin for the season highlight at Wimbledon. The stadium with the Centre Court and seats up to 4,500 spectators is named after German tennis legend Steffi Graf, who won the tournament a total of nine times.

About MAMMOTION

MAMMOTION is dedicated to cultivating an intelligent, high-quality, eco-friendly outdoor lifestyle through innovative robotic solutions. As the company behind the LUBA 2 AWD series, recognized as one of TIME’s Best Inventions of 2024, the versatile YUKA series, and LUBA mini AWD and YUKA mini series, MAMMOTION is transforming lawn care for both professionals and consumers. The mission is to pave the way for a more sustainable and efficient outdoor experience worldwide.

SOURCE Mammotion Technology

• Sublingual nano technology delivers caffeine rapidly to the blood stream, bringing its unique disruptive benefits to the Pre-workout market

• Initial production has commenced with six flavor options

• Expanded pre-launch consumer testing planned for Q2 2025

• Aspire to launch BUZZ BOMB™ at two major upcoming fitness conventions

• Marketing plan focused on cost-effective multi-channel digital strategy targeting primary influencers, direct response sales and traditional retail sales channels

• Global pre-workout supplements market size is expected to reach $27.97 billion by 2030, registering a CAGR of 5.9% from 2025 to 2030

HUMACO, PUERTO RICO and NEW YORK, NY / ACCESS Newswire / May 28, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) (“Aspire” or the “Company”), a developer of a multi-faceted patent-pending drug delivery technology, today announced the brand name BUZZ BOMB™ and anticipated market launch for its novel sublingual pre-workout supplement. BUZZ BOMB™ features 50mg of caffeine and is designed to support sustained energy and mental focus, helping athletes and fitness enthusiasts maximize their performance potential.

Aspire has commenced initial production of BUZZ BOMB™, its single serving pre-workout caffeine supplement utilizing Aspire’s patent-pending and proprietary sublingual delivery technology.The pre-workout formula is conveniently packaged in a single serving packet for easy on-the-go use. Consumers will have a choice of six BUZZ BOMB™ flavors, including Tropical Fruit, Mixed Berry, Watermelon, Lemon Lime, Peach Mango, and Mocha Coffee.

Fitness Convention Booth and Sponsor Events for BUZZ BOMB™ Launch

The Company expects to begin expanded pre-launch consumer testing of this supplement product during the second quarter of 2025. In August, the Company will have a booth and be an event sponsor at two of the largest fitness conferences in the nation where over 50,000 people interested in health, fitness, optimization, nutrition, and overall wellbeing will be able to taste, sample, and experience the BUZZ BOMB™ pre-workout supplement.

FITCON Expo
https://fitcon.com/

August 1-2, 2025
Mountain America Expo Center, Salt Lake City, Utah

The Fit Expo™
https://thefitexpo.com/cities/anaheim/
August 2-3
The Anaheim Convention Center, Anaheim, CA

Management Commentary

“The introduction of Aspire’s caffeine-based “Buzz Bomb™” Sublingual Pre-Workout energy supplement has the ideal unique characteristics to disrupt the fast-growing, multi-billion-dollar Sports Nutrition and Fitness market,” said Kraig Higginson, Chief Executive Officer of Aspire. “We are excited about the early feedback from fitness trainers and athletes-who love how clean and simple our product is–and we look forward to the implementation of our phased marketing plan as we prepare for our market launch in the early third quarter. Initial production, performed by Desert Stream, a leading private label manufacturer in the health and wellness industry, has proceeded as planned and we expect to have ample product available for consumer testing and launch.

While we are initially focused on the fitness pre-workout market, we believe the product also has tremendous broad market appeal in the Cognitive Focus and Energy Boost markets for professionals seeking a safe, healthy way to meet energy demands at work. We believe it may also appeal to a growing Health and Nutrition market as a weight loss enhancement, and as a coffee alternative, providing the taste, energy, and cognitive boost of coffee, while on the go, without the adverse effects of disrupting the gut micro biome and the liver, that is associated with long term coffee consumption.”

Higginson added, “As part of our commercial and revenue strategy, BUZZ BOMB™, is expected to provide Aspire with the opportunity for rapid, cost-effective market entry, and early revenue and cash flow while we complete our FDA clinical trials and application process for our high-dose aspirin product.”

BUZZ BOMB™: Disruptive Characteristics

The Pre-Workout supplement market segment is flooded with many options for energy boosting and hydration products. Many, if not most, of these products today are based on a powdered “mix + water” combination that take 20-30 minutes to digest and begin to provide performance benefits. This disadvantage complicates use, response management, caffeine control, and effectiveness. In contrast, Buzz Bomb™ provides nearly instant energy, in easy-to-use small sublingual packets, which can be taken right before and during work out as needed.

Market research shows that immediacy, ease of use and time management (take as needed, when needed) ranks highest in consumer preferences. Buzz Bomb™ offers potentially disruptive benefits and product characteristics that is expected to drive market penetration with significant differentiation, leading to rapid customer conversion, acquisition, and brand identity in this market.

Aspire’s sublingual nano technology is designed to deliver caffeine directly to the blood stream, bringing its unique disruptive benefits to the Pre-Workout market. These unique benefits provide significant product differentiation from powder mix beverage products that currently dominate the market segment.

BUZZ BOMB™ Disruptive Features:

• Speed – works nearly immediately vs. 20-30 minutes

• Convenience – easy to use small packets vs. mix beverages

• Energy management – use as needed, when needed to manage energy

• Single Safe Ingredients – well known benefits and use of caffeine

• Low manufacturing & packaging costs – competitive pricing with high margin potential

• Easy powerful product demonstration – enabling low-cost sample kits

Pre-workout Supplements Market & Growth Drivers

According to Research and Market Reports recent report, “The global pre-workout supplements market size is expected to reach $27.97 billion by 2030, registering a CAGR of 5.9% from 2025 to 2030.”

Growth Drivers

• Rising fitness culture and gym memberships

• Consumer focus on performance and recovery

• Expanding demographics (women, Gen Z, casual exercisers)

• Growth of RTD (“Ready To Drink”- no mixing) formats & natural formulations

• Digital fitness and influencer-led marketing

About the Aspire Targeted Oral Delivery Platform

Aspire’s technology delivers a soluble, fast acting granular or powder formulation which has been developed by using our patent-pending methodology, and “trade secret” process. The technology’s new mechanism of action allows for rapid sublingual absorption and entry into the bloodstream of supplements and other substances. The benefits of “rapid absorption” are to provide rapid impact in more precise quantities.

About Aspire Biopharma, Inc.

Headquartered in Humacao, Puerto Rico, Aspire Biopharma has developed a disruptive technology through a Novel Soluble Formulation which can deliver supplements and drugs rapidly and precisely. For more information, please visit www.aspirebiolabs.com.

Safe Harbor Statement

Certain statements made in this communication are “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may generally be identified by the use of words such as “estimate,” “projects,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “would,” “should,” “future,” “propose,” “potential,” “target,” “goal,” “objective,” “outlook” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding the financial position, business strategy and the plans and objectives of management for future operations. These statements are based on various assumptions, whether or not identified in this communication, and on the current expectations of Aspire’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by any investor as a guarantee, an assurance, a prediction or a definitive statement of fact or probability. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the control of the parties, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Aspire Biopharma Holdings, Inc.

Contact

TraDigital IR
Kevin McGrath
+1-646-418-7002
kevin@tradigitalir.com

SOURCE: Aspire Biopharma Holdings, Inc.

View the original press release on ACCESS Newswire

The news: Nvidia reported revenue of US$44.1 billion ($68.6 billion) for the first quarter of fiscal 2026, up 12% from the previous quarter and up 69% from a year ago, with data centre revenue of US$39.1 billion.

The forecast was in line with analysts’ estimates, according to data compiled by Bloomberg.

The numbers:
The company incurred a US$4.5 billion charge in the quarter due to new US export licensing requirements for H20 products to China, resulting in US$2.5 billion in H20 revenue that could not be shipped, it said.

Nvidia’s outlook for fiscal Q2 reflects a loss in H20 revenue of approximately US$8 billion due to the recent export control limitations, it said. It expects total revenue to be US$45 billion, plus or minus 2%.

Gross margin for the first quarter was 60.5%, or 71.3% excluding the H20 charge, and diluted earnings per share were 76 US cents per share, or 96 US cents per share excluding the H20 charge.

Nvidia shares rose more than 2.5% in after-hours trading after the result.

The company announced full-scale production of its Blackwell NVL72 AI supercomputer and said it will pay a US$0.01 dividend per share on 3 July.

What they said: “Global demand for NVIDIA’s AI infrastructure is incredibly strong,” Huang said in a statement released ahead of an investor briefing.

“AI inference token generation has surged tenfold in just one year, and as AI agents become mainstream, the demand for AI computing will accelerate,” he added.

“Countries around the world are recognizing AI as essential infrastructure — just like electricity and the internet — and NVIDIA stands at the center of this profound transformation.”

“Our breakthrough Blackwell NVL72 AI supercomputer — a ‘thinking machine’ designed for reasoning— is now in full-scale production across system makers and cloud service providers,”

LOGAN – Fitness technology company iFIT Inc. has formed a new Science Council aimed at embedding cutting-edge scientific research into its personalized fitness offerings.

The council, made up of experts in fields such as sleep medicine, cognitive performance, women’s health, and longevity, will guide iFIT’s efforts to integrate biometric data and health markers into its interactive training programs. The Logan-based company says this will enhance how workouts adapt in real time to a user’s performance and wellness profile.

“Health and wellness journeys are deeply personal—each of us starts from a different place,” said Kevin Duffy, CEO of iFIT in a release. “The iFIT Science Council allows us to translate that science into actionable, everyday routines.”

The inaugural council includes:

• Dr. Darshan Shah, longevity and health optimization expert, who also serves as iFIT’s Chief Medical Advisor

• Mona Sharma, holistic nutritionist and wellness strategist

• Louisa Nicola, neurophysiologist and performance coach

• Dr. Michael Breus, clinical psychologist and sleep expert

• Dr. Duncan French, high-performance sports scientist

• Dr. Vonda Wright, orthopedic surgeon and women’s health authority

• Dr. Rangan Chatterjee, functional medicine expert and bestselling author

Dr. Shah emphasized the shift away from “one-size-fits-all” workouts.

“By harnessing real biomarker data and the latest scientific research, we can tailor truly science-backed workouts to each individual,” he said in a release.

iFIT plans to incorporate heart-rate variability, recovery metrics and other biometric signals into its platforms to customize workouts and wellness plans.

The connected fitness market continues to grow, where companies target users looking for hyper-personalized training solutions. iFIT, headquartered in Logan, offers workouts via brands such as NordicTrack, ProForm, and Freemotion.

With energizing DJ beats, a spectacular light show, and a club-like atmosphere, Hrvatski Telekom has transformed Zagreb into the stage for the first Gym Rave in Croatia. It was an event combining music, technology, and fitness in a way previously experienced only in metropolises such as Berlin, London, New York, and Los Angeles.

More than 200 participants trained, danced and competed in six dynamic fitness challenges at THE Fitness and Padel Hall. The most successful won valuable prizes, including the latest Apple Watch S10. Gym Rave is a new global trend that brings the energy of a night out into the fitness world, creating a motivating environment where you can work out to music and light effects. 

One of the technological highlights that evening was a holographic demonstration of the Apple Watch S10’s features, which participants used to track their progress during the challenges. The event also showcased Hrvatski Telekom’s MultiSIM service, which connects a smartphone and smartwatch using the same number, providing an ideal solution for an active lifestyle and complete freedom of movement without the need to carry a phone.